Stock Screener App

Frei -

Installieren

Diagnostics & Research

4.3648

0.46% -0.0202

Endra Life Sciences Inc (NDRA)

Überblick Nachrichten Preisverlauf Financials Forum Prognose Aktiensplit

Finanzdaten der Endra Life Sciences Inc-Aktie (NDRA)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-06-30	2024-03-31	2023-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Operating Expenses	11.45% 1.3011	1.4693	2.2309	2.7805	1.4578
Depreciation and Amortization	32.13% 0.00936	0.0138	0.00869	0.0153	0.0219
Operating Income/Loss	11.45% -1.3011	-1.4693	-2.2309	-2.7805	-1.4578
Income/Loss From Continuing Operations Before Tax	18.29% -1.2259	-1.0363	-2.2292	-2.7757	-1.4595
Income Tax Expense/Benefit	-	-	-	-	-
Income/Loss From Continuing Operations After Tax	18.29% -1.2259	-1.0363	-2.2292	-2.7757	-1.4595
Net Income/Loss	18.29% -1.2259	-1.0363	-2.2292	2.7757	-1.4595
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	5.5514	-
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

WAT

$298.84

1.21%

DGX

$178.44

0.98%

NTRA

$162.85

1.61%

LH

$276.93

0.45%

MTD

$1,303.12

1.50%

IQV

$188.66

1.27%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters